Pérez-Mato, M., Dopico-López, A., Akkoc, Y., López-Amoedo, S., Correa-Paz, C., Candamo-Lourido, M., . . . Campos, F. (2024). Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke.
Citación estilo ChicagoPérez-Mato, María, et al. Preclinical Validation of Human Recombinant Glutamate-oxaloacetate Transaminase for the Treatment of Acute Ischemic Stroke. 2024.
Cita MLAPérez-Mato, María, et al. Preclinical Validation of Human Recombinant Glutamate-oxaloacetate Transaminase for the Treatment of Acute Ischemic Stroke. 2024.
Precaución: Estas citas no son 100% exactas.